Unknown

Dataset Information

0

High water vs. ad libitum water intake for autosomal dominant polycystic kidney disease: a randomized controlled feasibility trial.


ABSTRACT:

Background

Vasopressin stimulates cyst growth in autosomal dominant polycystic kidney disease (ADPKD) and is a key therapeutic target. Evaluation of high water intake as an alternative to pharmacological vasopressin blockade is supported by patients. However feasibility, safety and adherence-promoting strategies required to deliver this remain unknown.

Aims

Assess the feasibility of a definitive randomized high water intake trial in ADPKD.

Methods

In this prospective open-label randomized trial, adult ADPKD patients with eGFR ? 20 ml/min/1.73 m2 were randomized to prescribed high water (HW) intake targeting urine osmolality (UOsm) ?270 mOsm/kg, or ad libitum (AW) intake (UOsm >300 mOsm/kg). Self-management strategies including home-monitoring of urine-specific gravity (USG) were employed to promote adherence.

Results

We enrolled 42 participants, baseline median eGFR (HW 68.4 [interquartile range (IQR) 35.9-107.2] vs. AW 75.8 [IQR 59.0-111.0 ml/min/1.73 m2, P = 0.22) and UOsm (HW 353 [IQR 190-438] vs. AW 350 [IQR 240-452] mOsm/kg, P = 0.71) were similar between groups. After 8 weeks, 67% in the HW vs. 24% in AW group achieved UOsm ?270 mOsm/kg, P = 0.001. HW group achieved lower UOsm (194 [IQR 190-438] vs. 379 [IQR 235-503] mOsm/kg, P = 0.01) and higher urine volumes (3155 [IQR 2270-4295] vs. 1920 [IQR 1670-2960] ml/day, P = 0.02). Two cases of hyponatraemia occurred in HW group. No acute GFR effects were detected. In total 79% (519/672) of USG were submitted and 90% (468/519) were within target. Overall, 17% withdrew during the study.

Conclusion

DRINK demonstrated successful recruitment and adherence leading to separation between treatment arms in primary outcomes. These findings suggest a definitive trial assessing the impact of high water on kidney disease progression in ADPKD is feasible.

SUBMITTER: El-Damanawi R 

PROVIDER: S-EPMC7133783 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

High water vs. ad libitum water intake for autosomal dominant polycystic kidney disease: a randomized controlled feasibility trial.

El-Damanawi R R   Lee M M   Harris T T   Cowley L B LB   Bond S S   Pavey H H   Sandford R N RN   Wilkinson I B IB   Karet Frankl F E FE   Hiemstra T F TF  

QJM : monthly journal of the Association of Physicians 20200401 4


<h4>Background</h4>Vasopressin stimulates cyst growth in autosomal dominant polycystic kidney disease (ADPKD) and is a key therapeutic target. Evaluation of high water intake as an alternative to pharmacological vasopressin blockade is supported by patients. However feasibility, safety and adherence-promoting strategies required to deliver this remain unknown.<h4>Aims</h4>Assess the feasibility of a definitive randomized high water intake trial in ADPKD.<h4>Methods</h4>In this prospective open-l  ...[more]

Similar Datasets

| S-EPMC4145867 | biostudies-literature
| S-EPMC3022242 | biostudies-literature
| S-EPMC2843931 | biostudies-literature
| S-EPMC6716585 | biostudies-literature
| S-EPMC2837604 | biostudies-literature
| S-EPMC3791976 | biostudies-literature
| S-EPMC4341484 | biostudies-other